A drug manufacturer is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.
The French company Sanofi on Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.
In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac.
The agency said consumers could consider taking another heartburn medicine or contact their doctor.
Health Canada also said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. The agency issued a precautionary request last month for companies to stop distributing the medication.
Several drugstore chains have already removed Zantac and generic versions from store shelves.
—With a file from The Canadian Press
The Associated Press
Mediated talks are scheduled to begin Nov. 28
Annual attraction at Grouse Mountain raises funds for BC Children’s Hospital
Researchers looked at a group of 1,152 people in Vancouver who reported substance use and chronic pain
Central Cariboo Search and Rescue deputy chief challenges motorists to break the habit
Winter in Paris event the largest fundraiser of the year for the local clubs
Sean McKenzie pleaded guilty to second-degree murder of 28-year-old Amelie Christelle Sakkalis